Form 4: Aspen Aerogels CFO Boosts Equity Holdings with Grants

Aspen Aerogels' CFO and Treasurer, Grant Douglas Thoele, reported significant equity awards including Restricted Stock Units and stock options.

Summary

• Grant Douglas Thoele, CFO & Treasurer of Aspen Aerogels Inc. (ASPN), acquired 55,298 Restricted Stock Units (RSUs) on March 4, 2026, at a price of $0.
• These RSUs will vest in three equal annual installments on March 4, 2027, March 4, 2028, and March 4, 2029.
• On March 5, 2026, 2,368 shares of Common Stock were disposed of at $3.27 per share to satisfy minimum statutory tax withholding requirements related to RSU vesting.
• Thoele also acquired 74,893 Stock Options (Right to Buy) on March 4, 2026, with an exercise price of $3.35.
• The stock options will vest in three equal annual installments on March 4, 2027, March 4, 2028, and March 4, 2029, and have an expiration date of March 4, 2036.
• Following these transactions, Thoele beneficially owns 9,014 shares of Common Stock and 69,308 RSUs, totaling 78,322 shares.
• The total number of derivative securities beneficially owned after the transaction is 74,893 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, primarily due to the increased alignment of the CFO's financial interests with the long-term performance of Aspen Aerogels, which is generally favorable for shareholders.

Positives

• The acquisition of 55,298 RSUs and 74,893 stock options by the CFO indicates a strong alignment of management's long-term interests with shareholder value.
• Equity grants are a common form of executive compensation designed to incentivize performance and retention.

Negatives

• A disposition of 2,368 shares occurred to cover tax withholding, which is a standard practice but results in a reduction of direct share ownership.

Future Outlook

The acquired Restricted Stock Units and stock options are subject to a vesting schedule, with one-third of the shares vesting annually on March 4, 2027, March 4, 2028, and March 4, 2029. The stock options have an expiration date of March 4, 2036.

Industry Context

StockSavvy.ai notes that the granting of equity awards, such as RSUs and stock options, to key executives like the CFO is a standard practice across industries. This compensation structure is designed to align the interests of management with those of shareholders by tying a significant portion of their compensation to the company's long-term stock performance.

Stakeholder Impact

• Shareholders: The grants align the CFO's incentives with long-term shareholder value, potentially leading to more focused efforts on company growth and stock appreciation.

Next Steps

• Vesting of one-third of the RSUs and stock options on March 4, 2027.
• Vesting of an additional one-third of the RSUs and stock options on March 4, 2028.
• Vesting of the remaining one-third of the RSUs and stock options on March 4, 2029.

Key Dates

Recommendation

The grants of Restricted Stock Units and stock options to the CFO indicate continued commitment and alignment of management's interests with long-term shareholder value, which is a positive signal. However, this Form 4 filing alone does not provide sufficient operational or financial data to warrant a change in a broader investment thesis, thus a 'hold' recommendation is appropriate based solely on this information.

Keywords

Aspen Aerogels, ASPN, Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Executive Compensation, CFO, Equity Grant